Development of Thymol microsponges loaded In situ gel for the treatment of Periodontitis.

CONCLUSION: Thus THLMG decreased infiltration of inflammatory cells and prevented osteoclatogenesis and osteoblast apoptosis which further favored decrease in inflammation and alveolar bone loss in periodontitis. Thus THLMG could be a better alternative to synthetic antimicrobials and antibiotics to treat periodontitis. PMID: 32753013 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32753013?dopt=Abstract

Source: Current Drug Delivery - August 2, 2020 Category: Drugs & Pharmacology Authors: Patole VC, Chaudhari SP Tags: Curr Drug Deliv Source Type: research

More News: Drugs & Pharmacology | Study